APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
Portfolio Pulse from
Robbins LLP has announced a class action lawsuit against Applied Therapeutics, Inc. for investors who acquired securities between January 3, 2024, and December 2, 2024. Applied Therapeutics is a biopharmaceutical company focused on rare diseases.
December 24, 2024 | 12:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Applied Therapeutics, Inc. for securities acquired in 2024, potentially impacting investor confidence and stock price.
The announcement of a class action lawsuit is likely to negatively impact investor sentiment and could lead to a decrease in stock price due to potential legal liabilities and reputational damage.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100